Form4insider filings, from the source

SEC Form 4 · accession 0001645627-18-000069

ENDONOVO THERAPEUTICS, INC. · ENDV

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Michael Scott Mann
Officer — President
Period of report
Oct 29, 2018
Accepted (ET)
Nov 2, 2018 · 4:52 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockOct 29, 2018P2,000$0.0426A26,092,498D
Common StockOct 30, 2018P1,000$0.041A26,093,498D
Common StockOct 30, 2018P2,000$0.0408A26,095,498D
Common StockOct 31, 2018P2,000$0.0433A26,097,498D
Common StockOct 31, 2018P1,000$0.0399A26,098,498D
Common StockOct 31, 2018P1,000$0.0395A26,099,498D
Common StockOct 31, 2018P1,000$0.0392A26,100,498D
Common StockOct 31, 2018P1,000$0.0395A26,101,498D
Common StockOct 31, 2018P2,000$0.0392A26,103,498D
Common StockOct 31, 2018P1,000$0.036A26,104,498D
Common StockOct 31, 2018P1,000$0.0375A26,105,498D
Common StockOct 31, 2018P1,000$0.0382A26,106,498D
Common StockOct 31, 2018P2,000$0.039A26,108,498D
Common StockOct 31, 2018P2,000$0.0382A26,110,498D
Common StockOct 31, 2018P1,000$0.0386A26,111,498D
Common StockOct 31, 2018P1,000$0.041A26,112,498D
Common StockOct 31, 2018P1,000$0.0412A26,113,498D
Common StockOct 31, 2018P5,000$0.0358A26,118,498D
Common StockOct 31, 2018P1,000$0.0358A26,119,498D
Common StockOct 31, 2018P1,000$0.0356A26,120,498D
Common StockOct 31, 2018P1,000$0.0356A26,121,498D
Common StockNov 1, 2018P1,000$0.04A26,122,498D
Common StockNov 1, 2018P1,000$0.038A26,123,498D
Common StockNov 1, 2018P1,000$0.0377A26,124,498D

Table II — derivative securities

No Table II lines on this filing.